LBCL: Do Genes Shape CAR T Outcomes?

New research suggests that DNA variants help predict toxicity and response in CAR T-cell therapy for large B-cell lymphoma.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/lbcl-do-genes-shape-car-t-outcomes-2025a1000vb0?src=rss

Author :

Publish date : 2025-11-12 07:33:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

LBCL: Do Genes Shape CAR T Outcomes?

Country Doctor: Shining a Powerful Lens on Rural Medicine

The Push for Better Evidence on Microplastics and Health

Related Posts

Intensified Meds and Better Adherence Both Key to BP Control

Insect Protein Nears Mainstream as EU Approvals Expand

Biomarkers May Predict Omalizumab Response in Urticaria

Hydroxyurea and Pregnancy: Safety Data Provide Reassurance

Sickle Cell Pain Management in the ED Remains Suboptimal

Chemotherapy-Free Triplet ‘Sets a New Benchmark’ in Follicular Lymphoma

Intensified Meds and Better Adherence Both Key to BP Control

Biomarkers May Predict Omalizumab Response in Urticaria

Hydroxyurea and Pregnancy: Safety Data Provide Reassurance

Sickle Cell Pain Management in the ED Remains Suboptimal

Chemotherapy-Free Triplet ‘Sets a New Benchmark’ in Follicular Lymphoma

‘This Would Be a Hugely Important Finding’: What We Heard This Week

Alzheimer’s Benefits May Continue After Donanemab Treatment Ends, Data Suggest

Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV

Categories

Archives